Pyrrolidinedithiocarbamate ammonium

Discontinued Product

0727 has been discontinued.

View all NF-κB and IκB products.
Description: Inhibits NF-κB, prevents increase in NOS mRNA
Alternative Names: PDTC
Datasheet
Citations (8)
Reviews (1)
Pathways (1)

Biological Activity for Pyrrolidinedithiocarbamate ammonium

This inhibitor of nuclear factor κB (NF-κB) prevents the increase in NO-synthase mRNA by interleukin-1, without affecting the formation of NO-synthase mRNA produced by cAMP.

Technical Data for Pyrrolidinedithiocarbamate ammonium

M. Wt 164.28
Formula C5H12N2S2
Storage Store at RT
CAS Number 5108-96-3
PubChem ID 73343
InChI Key MDDIUTVUBYEEEM-UHFFFAOYSA-N
Smiles [NH4+].[S-]C(N1CCCC1)=S

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

Tocris products are intended for laboratory research use only, unless stated otherwise.

Product Datasheets for Pyrrolidinedithiocarbamate ammonium

References for Pyrrolidinedithiocarbamate ammonium

References are publications that support the biological activity of the product.

Bessho et al (1994) Pyrrolidine dithiocarbamate, a potent inhibitor of nuclear factor κB (NF-κB) activation, prevents apoptosis in human promyelocytic leukemia HL-60 cells and thymocytes. Biochem.Pharmacol. 48 1883 PMID: 7986199

Eberhardt et al (1994) Pyrrolidine dithiocarbamate differentially affects 1β- and cAMP-induced NO-synthase expression in rat renal mesangial cells. Biochem.Biophys.Res.Commun. 200 163 PMID: 7513157

Schini-Kerth (1994) Pyrrolidine dithiocarbamate selectively prevents the expression of the inducible nitric oxide synthase in the rat aorta. Eur.J.Pharmacol. 265 83 PMID: 7533726

View Related Products by Product Action

View all NF-κB and IκB Inhibitors

Keywords: Pyrrolidinedithiocarbamate ammonium, Pyrrolidinedithiocarbamate ammonium supplier, inhibitors, inhibits, NF-κB, NF-kappaB, NF-kB, NOS, mRNA, NFκB, NFkappaB, Nitric, Oxide, Signaling, Signalling, IκB, IkappaB, Nuclear, Factor, Kappa, B, Transcription, Factors, PDTC, Other, NF-kB/IkB, 0727, Tocris Bioscience

8 Citations for Pyrrolidinedithiocarbamate ammonium

Citations are publications that use Tocris products. Selected citations for Pyrrolidinedithiocarbamate ammonium include:

Ishizuka et al (2016) PAFR activation of NF-& #954;B p65 or p105 precursor dictates pro-and anti-inflammatory responses during TLR activation in murine macrophages Scientific Reports 6 32092 PMID: 27554194

Muxel et al (2013) NF-κB drives the synthesis of melatonin in RAW 264.7 macrophages by inducing the transcription of the arylalkylamine-N-acetyltransferase (AA-NAT) gene. BMC Cancer 7 e52010 PMID: 23284853

Birmingham et al (2009) Novel mechanism for obesity-induced colon cancer progression. Carcinogenesis 30 690 PMID: 19221001

Nadeem (2017) IL-17A causes depression-like symptoms via NFκB and p38MAPK signaling pathways in mice: Implications for psoriasis associated depression. Cytokine 97 14 PMID: 28570931


Reviews for Pyrrolidinedithiocarbamate ammonium

Average Rating: 5 (Based on 1 Review.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%

Have you used Pyrrolidinedithiocarbamate ammonium?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Filter by:


PDTC inhibits HOCl-LDL-induced CaMKII oxidation.
By Chintan Koyani on 10/22/2018
Assay Type: In Vitro
Species: Mouse
Cell Line/Tissue: Cardiomyocytes

HL-1 cardiomyocytes were pre-treated with Pyrrolidinedithiocarbamate (PDTC, 1 mM), Tempol (1 mM) or N-Acetylcysteine (NAC, 1 mM) for 30 min and stimulated with HOCl-LDL (200 µg/ml) for 2 h to follow CaMKII oxidation using Western blot.

review image

Pathways for Pyrrolidinedithiocarbamate ammonium

NF-κB Signaling Pathway

NF-κB Signaling Pathway

NF-κB signaling plays an important role in inflammation, the innate and adaptive immune response and stress. Dysregulated signaling can occur in inflammatory and autoimmune diseases.